Open Access Open Access  Restricted Access Subscription or Fee Access

Exploring Pharmacological Mechanism Of Pteridines And Its Derivatives Against Neurodegenerative Disorders Using Network Pharmacology And Molecular Docking Techniques

SHREYA G M

Abstract


Objectives: Pteridines have been identified via various research and shown therapeutic efficacy in Neurodegenerative disorders(ND) preclinical models. In the current study, a network pharmacology technique was applied to determine the underlying mechanism of the pteridines' protective effects on ND. Network pharmacology was utilised in order to reveal the interactions between medications and the targets of illnesses, and it is capable of completely articulating the complexity between diseases and medications. The identification of diverse drug-target interactions using network pharmacology may be utilised to discover novel medications for difficult conditions like ND. Pteridines have been found in various studies, and preclinical models demonstrate their medicinal efficacy.

Methods: In this study, the binding affinity of 30 pteridines and their derivatives to the targeted proteins was evaluated (PEX-1 and PEX-13) . Pathway analysis for these targets showed peroxisomal biogenesis pathway. A virtual tool called PyRx was used to carry out the molecular docking. The research was done computationally using information and structure of protein and phytocompounds from UniprotKB, DrugBank, GeneCards, and PubChem. Using the BIOVIA discovery studio software, the protein structure was evaluated. ADMET screening was used to analyze the ligands' pharmacological properties.

Results:  the results from this study showed that the phytocompounds Phosphorylated Dihydropteroate, Aminopterin, 5-methyltetrahydrofolic acid, Levoleucovorin, Triamterene, and Modufolin had the best binding affinity for the two targeted protein upon molecular docking.

Conclusion: These active ligands have appropriate anti-ND efficacy, according to the results of molecular docking and provides a theoretical basis and a clue for the pharmacological mechanism study of pteridines on neurodegenerative disorders


Keywords


Neurodegenerative disorders, network pharmacology, molecular docking, peroxisomal biogenesis pathway, ADMET screening

Full Text:

PDF

References


Reith W. Neurodegenerative diseases. Der Radiologe. 2018 Mar;58:241-58.

Emard JF, Thouez JP, Gauvreau D. Neurodegenerative diseases and risk factors: a literature review. Social science & medicine. 1995 Mar 1;40(6):847-58.

Checkoway H, Lundin JI, Kelada SN. Neurodegenerative diseases. IARC scientific publications. 2011 Jan 1(163):407-19.

Kritsky MS, Telegina TA, Vechtomova Y, Kolesnikov MP, Lyudnikova TA, Golub OA. Excited flavin and pterin coenzyme molecules in evolution. Biochemistry (Moscow). 2010 Oct;75:1200-16.

Daubner SC, Fitzpatrick PF. Pteridines In Encyclopedia of Biological Chemistry, Lennarz W, Lane M, eds.

Carmona-Martínez, V., Ruiz-Alcaraz, A. J., Vera, M., Guirado, A., Martínez-Esparza, M., & García-Peñarrubia, P.Therapeutic potential of pteridine derivatives: A comprehensive review. Medicinal research reviews, 2019; 39(2), 461–516.

Wishart, D. S., Knox, C., Guo, A. C., Shrivastava, S., Hassanali, M., Stothard, P., ... & Woolsey, J. (2006). DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic acids research, 34(suppl_1), D668-D672.

Li, Q., Cheng, T., Wang, Y., & Bryant, S. H. PubChem as a public resource for drug discovery. Drug discovery today, 2010;15(23-24), 1052-1057.

Gfeller, D., Grosdidier, A., Wirth, M., Daina, A., Michielin, O., & Zoete, V. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic acids research, 2014;42(W1), W32-W38.

Huang B, Huang C, Zhu L, Xie L, Wang Y, Zhu N. Exploring the Pharmacological Mechanisms of Tripterygium wilfordii Hook F against Cardiovascular Disease Using Network Pharmacology and Molecular Docking. BioMed Research International. 2021 Aug 16;2021.

Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A. GeneCards Version 3: the human gene integrator. Database. 2010 Jan 1;2010.

Szklarczyk, D., Gable, A. L., Nastou, K. C., Lyon, D., Kirsch, R., Pyysalo, S., ... & von Mering, C. The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic acids research, 2021;49(D1), D605-D612.

Mi H, Thomas P. PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Protein networks and pathway analysis. 2009:123-40.

Morris GM, Lim-Wilby M. Molecular modeling of proteins. Methods Mol Biol. 2008;443:365-82.

Rose PW, Prlić A, Altunkaya A, Bi C, Bradley AR, Christie CH, Costanzo LD, Duarte JM, Dutta S, Feng Z, Green RK. The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic acids research. 2016 Oct 27:gkw1000.

Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Chemical biology: methods and protocols. 2015:243-50.

Design LI. Pharmacophore and ligand-based design with Biovia Discovery Studio®. BIOVIA. California. 2014.

Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., ... & Cao, D. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Research,2021; 49(W1), W5-W14.

Wang, W., Wang, S., Liu, T., Ma, Y., Huang, S., Lei, L., ... & Ding, Y. Resveratrol: multi-targets mechanism on neurodegenerative diseases based on network pharmacology. Frontiers in Pharmacology, 2020;11, 694.

Zhou, W., Wang, Y., Lu, A., & Zhang, G. Systems pharmacology in small molecular drug discovery. International journal of molecular sciences, 2016;17(2), 246.

Walter, C., Gootjes, J., Mooijer, P. A., Portsteffen, H., Klein, C., Waterham, H. R., ... & Dodt, G. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. The American Journal of Human Genetics, 2001;69(1), 35-48.

Liu, Y., Björkman, J., Urquhart, A., Wanders, R. J., Crane, D. I., & Gould, S. J. PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders. The American Journal of Human Genetics, 1999;65(3), 621-634.

Spöttl, N., Wirleitner, B., Böck, G., Widner, B., Fuchs, D., & Baier-Bitterlich, G. Reduced pteridine derivatives induce apoptosis in human neuronal NT2/HNT cells. Immunobiology, 2000;201(3-4), 478-491.


Refbacks

  • There are currently no refbacks.